| Tag | Content |
|---|
EnhancerAtlas ID | HS098-21661 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr16:31463690-31464590 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HES2 | MA0616.2 | chr16:31464457-31464467 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr16:31464457-31464467 | GGCACGTGCC | - | 6.02 | | Stat6 | MA0520.1 | chr16:31463781-31463796 | CCTTTCCTGAGAATT | + | 6.44 | | mix-a | MA0621.1 | chr16:31463728-31463739 | ACTAATTAATT | - | 6.62 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_40557 | chr16:31463739-31466120 | K562 | | SE_48432 | chr16:31463520-31472106 | Psoas_Muscle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I031451 | chr16 | 31462841 | 31467525 |
|
Enhancer Sequence | AATATTTCTA GTAAGCCATT GGCTTAGAAA CCAGATTCAC TAATTAATTC ATTTACCCTT 60
TCATGATACA AAATTTTTTA ACTGAGTGAG GCCTTTCCTG AGAATTGAGC ACATGAGCTT 120
TGGTGCATGG ACCTGGAAAT CTCTGCTTCT TGAACTCCTA GGGGCTTCCT TTACTTCATT 180
CACTCCTGGT GCTCAGCAAA TTTCTGAATG GGGGAGGTTG GCCAGCCTGG GAGAGGTCAC 240
CCACGCCAGG AAGTCTCAGT ACCTCTCTAT TTATCCTATC ACTTGGGAAT CCTCTAGGAT 300
CTGTTTCAGG GAGTCTCTGG TTAGCCCTGA GACATAAGTG GTGCGGGTGA GACTCCTGGG 360
GCCTATCTCA GAGGTCCTCA CACCCCTGAG ATTAAATCAG TCAGGAGGCA GGGTGGAGAG 420
AGGAGTGTCC TATCAGGTCT GAGGAGGTTG TCAACTTCCT GGACTTCTTG CTAAGGACTC 480
CTCTTCCCAC CCTTCATGGG TAGCTGAGGT CAGGGAATCT GTAGGGACAA GACTTTCTTT 540
TAAATGCTAA TCTGCTGACT AACCCTGAGT CTGGGAATGC CTCCAAAATG TCAAGCTGAT 600
GTGTTTTTTT ATTTTTTGGT TTTGTTTTTT TTGTTTTTTT TTTGAAACGG AGTCTCACTC 660
TTTCATCCAA ACTGGGGTGC AGTGGCACGA TCTTGGCTCA CTGAAACCTC CACCTCCTGG 720
GTTCAAGCAA TTTTCCTGCC TCAACCTCCC AAGTAGCTGG GATTACAGGC ACGTGCCACC 780
ATGCCTGGCT AATTTTTATA TTTTTGGTAG AGACAGGGTT TCACCACGTT GGGCAGCCTG 840
GTCTCGAACT CCTGACCTCA GGTGATCTGC CCACCTCGGC CTCCCAAAGC GCTGGGAATA 900
|
